Literature DB >> 21393480

Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.

Hal E Broxmeyer1, Man-Ryul Lee, Giao Hangoc, Scott Cooper, Nutan Prasain, Young-June Kim, Coleen Mallett, Zhaohui Ye, Scott Witting, Kenneth Cornetta, Linzhao Cheng, Mervin C Yoder.   

Abstract

Cryopreservation of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) is crucial for cord blood (CB) banking and transplantation. We evaluated recovery of functional HPC cryopreserved as mononuclear or unseparated cells for up to 23.5 years compared with prefreeze values of the same CB units. Highly efficient recovery (80%-100%) was apparent for granulocyte-macrophage and multipotential hematopoietic progenitors, although some collections had reproducible low recovery. Proliferative potential, response to multiple cytokines, and replating of HPC colonies was extensive. CD34(+) cells isolated from CB cryopreserved for up to 21 years had long-term (≥ 6 month) engrafting capability in primary and secondary immunodeficient mice reflecting recovery of long-term repopulating, self-renewing HSCs. We recovered functionally responsive CD4(+) and CD8(+) T lymphocytes, generated induced pluripotent stem (iPS) cells with differentiation representing all 3 germ cell lineages in vitro and in vivo, and detected high proliferative endothelial colony forming cells, results of relevance to CB biology and banking.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393480      PMCID: PMC3100689          DOI: 10.1182/blood-2011-01-330514

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.

Authors:  David A Ingram; Laura E Mead; Hiromi Tanaka; Virginia Meade; Amy Fenoglio; Kelly Mortell; Karen Pollok; Michael J Ferkowicz; David Gilley; Mervin C Yoder
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

2.  High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10 years.

Authors:  H E Broxmeyer; S Cooper
Journal:  Clin Exp Immunol       Date:  1997-01       Impact factor: 4.330

3.  Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.

Authors:  E Gluckman; H A Broxmeyer; A D Auerbach; H S Friedman; G W Douglas; A Devergie; H Esperou; D Thierry; G Socie; P Lehn
Journal:  N Engl J Med       Date:  1989-10-26       Impact factor: 91.245

4.  T-lymphocyte recovery and function after cord blood transplantation.

Authors:  Paul Szabolcs
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

5.  Proliferative and cytotoxic responses of human cord blood T lymphocytes following allogeneic stimulation.

Authors:  G Risdon; J Gaddy; F B Stehman; H E Broxmeyer
Journal:  Cell Immunol       Date:  1994-03       Impact factor: 4.868

6.  Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells.

Authors:  H E Broxmeyer; G W Douglas; G Hangoc; S Cooper; J Bard; D English; M Arny; L Thomas; E A Boyse
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

Authors:  John E Wagner; Juliet N Barker; Todd E DeFor; K Scott Baker; Bruce R Blazar; Cindy Eide; Anne Goldman; John Kersey; William Krivit; Margaret L MacMillan; Paul J Orchard; Charles Peters; Daniel J Weisdorf; Norma K C Ramsay; Stella M Davies
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

8.  Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.

Authors:  H E Broxmeyer; G Hangoc; S Cooper; R C Ribeiro; V Graves; M Yoder; J Wagner; S Vadhan-Raj; L Benninger; P Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

9.  High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.

Authors:  Hal E Broxmeyer; Edward F Srour; Giao Hangoc; Scott Cooper; Stacie A Anderson; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-07       Impact factor: 11.205

10.  Umbilical cord and placental blood hematopoietic stem cells: collection, cryopreservation, and storage.

Authors:  J E Wagner; H E Broxmeyer; S Cooper
Journal:  J Hematother       Date:  1992
View more
  58 in total

1.  Mouse hematopoietic cell-targeted STAT3 deletion: stem/progenitor cell defects, mitochondrial dysfunction, ROS overproduction, and a rapid aging-like phenotype.

Authors:  Charlie Mantel; Steven Messina-Graham; Akira Moh; Scott Cooper; Giao Hangoc; Xin-Yuan Fu; Hal E Broxmeyer
Journal:  Blood       Date:  2012-06-04       Impact factor: 22.113

Review 2.  Generation of mature hematopoietic cells from human pluripotent stem cells.

Authors:  Padma Priya Togarrati; Kran Suknuntha
Journal:  Int J Hematol       Date:  2012-05-31       Impact factor: 2.490

3.  Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype.

Authors:  Francesca Masiello; Valentina Tirelli; Massimo Sanchez; Emile van den Akker; Girelli Gabriella; Maurizio Marconi; Maria Antonietta Villa; Paolo Rebulla; Ghazala Hashmi; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Transfusion       Date:  2013-09-04       Impact factor: 3.157

Review 4.  Cord blood research, banking, and transplantation: achievements, challenges, and perspectives.

Authors:  Hector Mayani; John E Wagner; Hal E Broxmeyer
Journal:  Bone Marrow Transplant       Date:  2019-05-14       Impact factor: 5.483

5.  Impact of long-term cryopreservation on single umbilical cord blood transplantation outcomes.

Authors:  Richard Mitchell; John E Wagner; Claudio G Brunstein; Qing Cao; David H McKenna; Troy C Lund; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-28       Impact factor: 5.742

6.  Mild Heat Treatment Primes Human CD34(+) Cord Blood Cells for Migration Toward SDF-1α and Enhances Engraftment in an NSG Mouse Model.

Authors:  Maegan L Capitano; Giao Hangoc; Scott Cooper; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

7.  Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming.

Authors:  Man Ryul Lee; Nutan Prasain; Hee-Don Chae; Young-June Kim; Charlie Mantel; Mervin C Yoder; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2013-04       Impact factor: 6.277

Review 8.  Enhancing engraftment of cord blood cells via insight into the biology of stem/progenitor cell function.

Authors:  Hal E Broxmeyer
Journal:  Ann N Y Acad Sci       Date:  2012-08       Impact factor: 5.691

Review 9.  Stem Cells: Potential Therapy for Neonatal Injury?

Authors:  Momoko Yoshimoto; Joyce M Koenig
Journal:  Clin Perinatol       Date:  2015-05-29       Impact factor: 3.430

Review 10.  Umbilical cord blood transplantation: the first 25 years and beyond.

Authors:  Karen K Ballen; Eliane Gluckman; Hal E Broxmeyer
Journal:  Blood       Date:  2013-05-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.